INTERVIEWS

QLife National Project Manager Lucy Abbot joins HPR to talk about the QLife Project, one of the programs created by her organization, the National LGBTI Health Alliance. It’s Australia’s first nationally oriented counselling and referral service for people from the LGBTI community. QLife offers phone counselling and web chat services. She explains why this is beneficial for LGBTI people and why it is relevant to health professionals.

In today’s interview, Melissa Kumar, the Events and Fundraising Manager of the Prince of Wales Hospital Foundation joins HPR to discuss the very important work she does for this hospital. She also promotes their upcoming 2018 El Camino Trek which will be held in Spain.

In this interview, Emeritus Professor Dorothy Bruck joins HPR to take about the work she does as the Chair of the Sleep Health Foundation. She also discusses about the prevalence of sleep disorders nowadays and shares very interesting medical facts about sleep.

In this segment, MS Research Australia’s CEO Dr. Matthew Miles joins the program to promote the global campaign “Kiss Goodbye to MS.” It’s a national initiative by MS Research Australia focused on raising critical funds for Australian MS research. He talks about the importance of raising funds for MS research due to the fact there is still no cure for it yet. He also discusses about his genuine desire to help those with this condition.

In this interview, Dr. Dominique Hes from the University of Melbourne joins HPR to talk about the amazing and cutting-edge work she has at Thrive Research Hub. The Plant Life Balance is one of the topics she emphasizes on as well as the benefits plants can have on people even when they are indoors.

Dr. Terry Wahls joins the program to talk about the upcoming 6th BioCeuticals Research Symposium 2018 to be held in Melbourne, Australia where she is one the speakers. She shares her own story about how she overcame multiple sclerosis (MS) with a clinically proven dietary protocol particularly designed to nourish brain and mitochondrial health. Dr. Wahls also discusses her desire to help others with the same condition.

Dr. James Hermiller, from The St. Vincent Medical Group at The Heart Center, discusses results from the study titled “The Abbott Post-Approval Study 1 MitraClip Registry: 1-year Results of the First 2,000 Patients in the Transcatheter Valve Therapy Registry” that was presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 2018 Scientific Sessions. To learn more about this research, you may view a slideshow presentation here.

Dr. Bilal Iqbal, from the Victoria Heart Institute Foundation, Canada, talks about the study titled “The Prognostic Impact of Revascularization Strategy in Acute Myocardial Infarction and Cardiogenic Shock: Insights from the British Columbia Cardiac Registry” that was presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 2018 Scientific Sessions.

Guest Bio: Dr. Bilal Iqbal is an interventional cardiologist having trained in London, UK. He is currently on works at Royal Jubilee Hospital, and is a Professor of Medical Sciences at the University of Victoria, Canada. Prior to his appointment in Victoria, Dr. Iqbal was a full-time Interventional Cardiologist at the Royal Brompton and Harefield Hospital in London, UK. He has ongoing basic science research interests in the signaling mechanisms underlying thrombosis and is actively involved in clinical research spanning all aspects of Interventional Cardiology with specific interests in statistical modelling and decision-analytic models.

Latest research shows that common therapy options for psoriasis can help reduce coronary plaque. In this interview, Dr. Nehal Mehta talks about the study results titled “Immunomodulatory Therapy Reduces Atherosclerotic Plaque Burden by Coronary Computed Tomography Angiography in Psoriasis at One-Year” that was presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 2018 Scientific Sessions.

Guest Bio: Dr. Nehal Mehta is the Chief of Inflammation and Cardiometabolic Diseases at the NIH in Bethesda MD. He is also a Professor of Clinical Medicine and an active attending physician in the coronary care unit at George Washington University. Dr. Mehta is an expert in general cardiology, lipidology, metabolism, and chronic disease effects on dyslipidemia. He has clinical and research interests in moving epidemiological observations into translational studies in humans, studying how inflammation affects insulin resistance, the metabolic syndrome, lipoprotein function, and atherosclerosis. He is a board certified in internal medicine, cardiology, and nuclear cardiology, and he utilizes novel imaging techniques to understand the effect of various exposures on subclinical atherosclerosis. Dr Mehta’s lab discovered that chronic inflammation in the body can be treated to reduce vascular diseases, and he is the PI on five major interventional trials as well as PI on a large cohort study following patients with inflammation over several years to understand the effects on cardiometabolic diseases.

Returning guest Dr. Hilary Baldwin, the Medical Director of the Acne Treatment & Research Center, discusses the triggers, symptoms, and latest treatment for rosacea, a chronic inflammatory skin condition.  Visit www.rosacearelief.com to learn more.

Guest Bio: Dr. Baldwin, the Medical Director of the Acne Treatment & Research Center, is a board certified dermatologist with nearly 25 years of experience. Her area of expertise and interest are acne, rosacea and keloid scars. Dr. Baldwin received her BA and MA in biology from Boston University. She became a research assistant at Harvard University before attending Boston University School of Medicine. She then completed a medical internship at Yale New Haven Hospital before becoming a resident and chief resident in dermatology at New York University Medical Center. Upon graduation and board certification in dermatology, she joined the faculty of the dermatology department at The State University of New York, ultimately becoming Associate Professor and Vice Chair of the department. Over 20 years at SUNY she cared for patients, taught countless students, and conducted numerous clinical studies. Dr. Baldwin has lectured extensively both nationally and internationally and published prolifically in journals. She served as a founding board member and second president of the American Acne and Rosacea Society.